中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
9期
1296-1297
,共2页
血栓通%尤瑞克林%脑梗死
血栓通%尤瑞剋林%腦梗死
혈전통%우서극림%뇌경사
Xueshuantong%Urinary Kallidinogenase%Brain infarction
目的 观察血栓通联合尤瑞克林治疗中老年人急性脑梗死的临床疗效.方法 将120例急性脑梗死患者随机分为两组,治疗组60例在常规治疗基础上给予0.9％氯化钠注射液250 ml+血栓通400 mg静脉滴注,0.9％氯化钠注射液100 ml+尤瑞克林0.15PNA单位静脉滴注,每天1次；对照组60例在常规治疗基础上仅给予0.9％氯化钠注射液250 ml+血栓通400 mg静脉滴注,每天1次,连续治疗2周,观察两组患者治疗前后神经功能缺损评分及临床疗效.结果 治疗组总有效率为91.7％,对照组总有效率71.7％,治疗组明显优于对照组(P＜0.01)；神经功能缺损评分治疗后明显高于治疗前,差异有统计学意义(P＜0.05).结论 血栓通联合尤瑞克林治疗中老年人急性脑梗死临床疗效显著,具有协同作用,安全性高,副作用少,值得临床推广使用.
目的 觀察血栓通聯閤尤瑞剋林治療中老年人急性腦梗死的臨床療效.方法 將120例急性腦梗死患者隨機分為兩組,治療組60例在常規治療基礎上給予0.9％氯化鈉註射液250 ml+血栓通400 mg靜脈滴註,0.9％氯化鈉註射液100 ml+尤瑞剋林0.15PNA單位靜脈滴註,每天1次；對照組60例在常規治療基礎上僅給予0.9％氯化鈉註射液250 ml+血栓通400 mg靜脈滴註,每天1次,連續治療2週,觀察兩組患者治療前後神經功能缺損評分及臨床療效.結果 治療組總有效率為91.7％,對照組總有效率71.7％,治療組明顯優于對照組(P＜0.01)；神經功能缺損評分治療後明顯高于治療前,差異有統計學意義(P＜0.05).結論 血栓通聯閤尤瑞剋林治療中老年人急性腦梗死臨床療效顯著,具有協同作用,安全性高,副作用少,值得臨床推廣使用.
목적 관찰혈전통연합우서극림치료중노년인급성뇌경사적림상료효.방법 장120례급성뇌경사환자수궤분위량조,치료조60례재상규치료기출상급여0.9％록화납주사액250 ml+혈전통400 mg정맥적주,0.9％록화납주사액100 ml+우서극림0.15PNA단위정맥적주,매천1차；대조조60례재상규치료기출상부급여0.9％록화납주사액250 ml+혈전통400 mg정맥적주,매천1차,련속치료2주,관찰량조환자치료전후신경공능결손평분급림상료효.결과 치료조총유효솔위91.7％,대조조총유효솔71.7％,치료조명현우우대조조(P＜0.01)；신경공능결손평분치료후명현고우치료전,차이유통계학의의(P＜0.05).결론 혈전통연합우서극림치료중노년인급성뇌경사림상료효현저,구유협동작용,안전성고,부작용소,치득림상추엄사용.
Objective To observe the effect of Xueshuantong combined with Urinary Kallidinogenase on acute cerebral infarction in middle-aged and aged people.Methods 120 patients with acute cerebral infarction were randomly divided into two groups,the treatment group was given 400mg Xueshuantong with 0.15PNA of Urinary Kallidinogenase,while the control group was only given 400mg Xueshuantong.After treatment for 2 weeks,the nerve function deficit score and the curative effect were compared between two groups.Results The curative effect of treatment group and control group was 91.7％ and 71.7％,respectively.The nerve function deficit score in two groups was decreased than before treatment,the difference between two groups was significant (P ＜ 0.05).Conclusion The effect of Xueshuantong combined with Urinary Kallidinogenase in treatment of acute cerebral infarction in middle-aged and aged people was confirmed with high safety and low side effects,which worthy of clinical application.
